Kips Bay Medical Announces the First eSVS® Mesh Implant by the Emory University Cardiothoracic Clinical Research Unit

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MINNEAPOLIS--(BUSINESS WIRE)--Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS), announced that on September 4, 2013, the Emory Heart & Vascular Center in Atlanta, Georgia, performed its first implant of an eSVS® Mesh. This implant was performed as part of the Kips Bay Medical eMESH I clinical feasibility trial currently being conducted for the U.S. Food and Drug Administration (FDA) in a number of preeminent cardiac surgery centers in both Europe and the United States.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC